Stock Quote
Access Pharmaceuticals, Inc. (ACCP.OB) (OTC BB)
sector: Healthcare .
industry: Pharmaceuticals - Generic & Specialty ยท
View ACCP on other exchanges
$3.10
23 Nov 2009
+0.00%
$3.10
$3.05
37,130
$3.13
$2.77
$5.00
$0.75
1.32
19,885
No news stories for this company within the last 30 days.
ACCP.OB
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Rouhandeh, Steven | Chairman of the Board | -- |
| Davis, Jeffrey | Chief Executive Officer, Director | 266,076 |
| Thompson, Stephen | Chief Financial Officer, Vice President, Treasurer, Secretary | 298,669 |
Profile
Access Pharmaceuticals, Inc. (Access) is a biopharmaceutical company focused on developing products based upon its nanopolymer chemistry technologies and other drug delivery technologies. As of December 31, 2008, the Company has one approved product, one product at Phase III of clinical development,... Full Description
Company Address
Access Pharmaceuticals, Inc.
2600 Stemmons Freeway
Suite 176
Dallas TX 75207
P: +1214.9055100
F: +1214.9055101
2600 Stemmons Freeway
Suite 176
Dallas TX 75207
P: +1214.9055100
F: +1214.9055101
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Amgen, Inc. | $56.25 | +0.87 |
| CuraGen Corporation | -- | -- |
| Endo Pharmaceuticals | $22.75 | +0.55 |
| ACCP.OB | Industry | |
|---|---|---|
| P/E(TTM) | -- | 3.57 |
| P/S(TTM) | 168.43 | 0.57 |
| ROI(TTM) | -- | 1.86 |
| ROE(TTM) | -- | 2.51 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | -- |
| EPS Est. (Current Year) | -0.90 |
| Total Revenue | $0.06M |
| Net Income | $-2.21M |
| EPS | $-0.24 |
